Performance of a Translucent Activator for LipiFlow Vectored Thermal Pulse (VTP) Treatment of Meibomian Gland Dysfunction

Jerry G Hu,1 Vin T Dang,2 Daniel H Chang,2 Damien F Goldberg,3 Cheryl McKinnon,4 Katherine Makedonsky,4 Michal Laron,4 Leilei Ji5 1Texas Eye & Laser Center, P.A., Hurst, TX, USA; 2Empire Eye and Laser Center, Bakersfield, CA, USA; 3Wolstan & Goldberg Eye Associates, Torrance, CA, USA; 4Johns...

Full description

Bibliographic Details
Main Authors: Hu JG, Dang VT, Chang DH, Goldberg DF, McKinnon C, Makedonsky K, Laron M, Ji L
Format: Article
Language:English
Published: Dove Medical Press 2022-03-01
Series:Clinical Ophthalmology
Subjects:
Online Access:https://www.dovepress.com/performance-of-a-translucent-activator-for-lipiflow-vectored-thermal-p-peer-reviewed-fulltext-article-OPTH
Description
Summary:Jerry G Hu,1 Vin T Dang,2 Daniel H Chang,2 Damien F Goldberg,3 Cheryl McKinnon,4 Katherine Makedonsky,4 Michal Laron,4 Leilei Ji5 1Texas Eye & Laser Center, P.A., Hurst, TX, USA; 2Empire Eye and Laser Center, Bakersfield, CA, USA; 3Wolstan & Goldberg Eye Associates, Torrance, CA, USA; 4Johnson & Johnson Surgical Vision, Inc., Milpitas, CA, USA; 5Johnson & Johnson Surgical Vision, Inc., Irvine, CA, USACorrespondence: Cheryl McKinnon, Johnson & Johnson Surgical Vision, Inc., 510 Cottonwood Drive, Milpitas, CA, 95035, USA, Tel +1 408 273 4014, Email cmckinno@its.jnj.comPurpose: Investigator feedback was used to assess the clinical use of the LipiFlow® System with the new translucent Activator Clear to successfully complete LipiFlow® treatments.Patients and Methods: This was a prospective, open-label clinical investigation. A total of 88 eyes (44 subjects) were treated using the LipiFlow® System with the new Activator Clear. Subjects diagnosed with bilateral meibomian gland dysfunction (MGD) were enrolled in the study. Each investigator performed a complete LipiFlow® treatment with the translucent Activator on both eyes of each subject. Investigators completed a questionnaire assessing the clinical use of the Activator Clear on a 5-point scale (1 – very difficult or strongly disagree, 3 – neutral, 5 – very easy or strongly agree).Results: The new translucent Activator provided successful LipiFlow® treatments in 100% of cases, with 95% confidence interval of (96%, 100%). Additionally, the investigators agreed or strongly agreed that the translucent components of the Activator Clear made it easy to access and position the activator with confidence on the subject’s eye.Conclusion: The overall investigators’ impressions on usage and functionality of LipiFlow® System with the translucent Activator were very positive. The Activator Clear enables doctors with efficient and confident positioning around patient eyelids to ensure successful LipiFlow® treatment when used as indicated.Keywords: LipiFlow® vectored thermal pulsation, Activator Clear
ISSN:1177-5483